Organophosphorus compounds are widely used for pest control in agriculture. Poisoning is frequent, especially in developing countries, due to suicide attempts and accidents with more than 200,000 deaths per year worldwide. Among the organophosphorus compounds, nerve agents are a subgroup with high toxicity for humans. The terrorist use of Sarin and VX in Japan (1) has shown the world that nerve agents are no longer restricted to chemical battlefields, but are a pertinent threat for civilian and military populations. Consequently, effective therapeutic preparedness is mandatory. Inhibition of acetylcholinesterase (AChE, EC 3.1.1.7) is regarded as the primary mechanism for the acute toxicity of all organophosphorus compounds (OP), nerve agents as well as pesticide OP, and therefore should be an integral part of casualty diagnosis and treatment. Therapeutic strategies are directed to competitively antagonise overstimulation of muscarinic receptors by antimuscarinics such as atropine, and to reverse AChE inhibition by reactivation with oximes, e.g. pralidoxime or obidoxime. The latter approach is crucial within neuromuscular synapses where atropine fails, since peripheral neuromuscular block eventually leads to respiratory failure. A lot of research has been performed over the last several decades, leading to a better understanding of individual reactions during and after inhibition [aging, spontaneous reactivation, oxime induced reactivation, formation of phosphoryloximes and their interactions; for review see (2) ]. It can be concluded that all of these reactions must be considered for the optimal treatment of poisoned patients.
DEVELOPMENT OF AN OPTIMAL TREATMENT REGIMEN

Treatment of signs and symptoms due to overstimulation of muscarinic receptors
Typical signs and symptoms of cholinergic crisis develop in direct correlation with the degree of acetylcholinesterase inhibition (3). In severe poisoning, respiratory depression, bronchospasm, bronchosecretion and weakness of the respiratory muscles call for immediate endotracheal suctioning and artificial ventilation. Generally, treatment with muscarinic receptor antagonists, e.g. atropine should achieve heart rate between 80 and 100 beats per minute, the absence of rales during auscultation, and skin dryness (axilla). Furthermore, frequent circulatory insufficiency may call for treatment with catecholamines to increase and maintain blood pressure (i.e. arterial mean pressure above 60 mm Hg with systolic pressure exceeding 100 mm Hg) as well as heart rate. In the later phase of severe poisoning, rales might be the result of cardiac insufficiency or (aspiration) pneumonia accompanied by elevated temperature and sweating, thus preventing the use of these parameters as clear indicators of atropine demand. In conclusion, in the acute phase of poisoning, atropine dosing should follow a protocol guaranteeing an early sufficient atropinisation. Such protocols are proposed in modern literature (4, 5) , recommending a starting dose of 2 mg i.v. followed by an observation period of 5 min. If there is no effect, this dose may be doubled every 5 min to10 min until muscarinic symptoms subside. With the 5th dose in this regimen, 62 mg of atropine would be administered, an amount that should suffice. For the ongoing treatment, especially at intensive care units, the whole clinical picture has to be considered and dosing of atropine should be performed with caution (e.g. 1 mg h -1 to 4 mg h -1 ) to avoid adverse effects.
Reactivation of acetylcholinesterase
As atropine is not able to counteract signs and symptoms caused by the overstimulation of nicotinic receptors, especially at neuromuscular endplates, the concept of reactivation of inhibited AChE was developed (6) , and pralidoxime (7) and obidoxime (8) were introduced into clinical therapy fifty years ago. Since the sixties, textbooks recommend 4 µg mL ) were needed to counteract neuromuscular block, bradycardia, hypotension and respiratory failure ..." (9) was extrapolated without critical evaluation for treatment of any OP-type-poisoning, using any oxime, and in any species. However, various OPs show quite different properties in reacting with AChE (10) and reactivation depends both on the properties of the OP-AChE conjugates and of the oxime used (2, 11) . Moreover, enormous differences between species have to be considered (12) . Based on reaction constants derived from experiments with human RBC-AChE, reasonable plasma concentrations of oximes for reactivation of insecticide as well as nerve agentinhibited AChE can be calculated (2, 11, (13) (14) (15) (16) (17) (18) (19) . Results indicate that AChE inhibited by most nerve agents and insecticide OPs can be reactivated with obidoxime at a plasma concentration of approximately 10 µmol L -1 . This plasma concentration can be adjusted by an i.v. bolus dose of 250 mg, followed by 750 mg of obidoxime per day. In actual emergency situations, this regimen proved effective in reactivating AChE inhibited by insecticide OP (11, 16, 20) .
Comparably, Pawar (21) showed reduced morbidity and mortality in moderately severe insecticide OPpoisoned patients treated with effective doses of pralidoxime (2 g loading dose, followed by 24 g per day). Hence, effective oximes should be administered in appropriate dosage as early as possible (e.g. by autoinjectors or i.v.) and effective concentrations should be maintained as long as reactivation is possible. The treatment period may be shortened to several hours in poisoning with OP where toxic concentrations persist only for a very short time in the body (e.g. sarin) or when OP-AChE-conjugates age quickly (e.g. soman). In contrast, in poisoning with persisting nerve agents (e.g. VX) or after ingestion of huge amounts of poison as frequently found in suicide poisoning, administration of oximes may be necessary for several days.
MONITORING OF THE CHOLINESTERASE STATUS
Assessment of therapeutic effectiveness in OPpoisoned patients is difficult due to a wide variety of therapeutic measures taken at intensive care units (e.g. artificial ventilation, sedation). To monitor the course of poisoning in OP-poisoned patients, a laboratory test system, called cholinesterase status, was developed (16, 22) and used in intensive care units ( Figure 1) (11, 20, 23, 24) . The cholinesterase status consisted of:
· Red blood cell (RBC)-AChE activity: Blood was immediately diluted bed-side 1:100 (v/v) with ice-cold phosphate-buffer (0.1 mol L -1 , pH 7.4; 0.03 % Triton X-100). AChE activity was determined according to a modified Ellman method (22 (29) . system with a capacity to perform 600 assays per day (25, 26) . Furthermore, for determination of RBCAChE and plasma BChE an improved portable device, appropriate for the use in the field was developed (27) .
To demonstrate the properties of cholinesterase status, a case report of parathion poisoning is presented here [compare (28, 29) ]. This example resembles a course of poisoning that might be expected in percutaneous intoxication with a persisting OP such as VX. A 45-year-old man ingested about 100 mL of a parathion-containing solution. On presentation to the emergency physician, the patient was unconscious with severe signs and symptoms of cholinergic crisis. After administration of 1.5 mg of atropine the patient was intubated and artificial ventilation was initiated. At the local hospital gastric lavage was performed and the patient was stabilized. After treatment with 2 bolus doses of obidoxime and atropine infusion, the patient was transferred to the intensive care unit of the toxicological department of the 2 nd Medical Clinic, Technical University, Munich. Here, the obidoxime regimen was started (250 mg i.v. bolus, followed by 750 mg per day), maintaining the therapeutic plasma level of about 10 µmol L -1 obidoxime (Figure 1, A, upper panel) . Due to the persisting poison load, only partial reactivation of RBCAChE could be achieved over approximately four days. During this period, very little aging occurred ( Figure  1 , B, mid panel) and BChE remained completely inhibited. When the poison load significantly decreased on the fourth day following initiation of the obidoxime regimen, complete AChE reactivation was achieved. Furthermore, based on RBC-AChE activity, reactivatability and obidoxime plasma concentration, a paraoxon concentration necessary for such a degree of inhibition could be calculated (29) by using the respective reaction constants (17) . The time course of this theoretical curve closely fits the actual time course of inhibitory activity, as determined in the poisoned patient (Figure 1, C, lower panel) .
In cases of exposure to nerve agents, early determination of RBC-AChE is mandatory to confirm clinical diagnosis without sophisticated verification of the agent used. For this purpose, the Test Mate® was developed by EQM research (27) . The device was tested in an international NBC-defence exercise (Precise Response 2006, Canada). During the training scenario, the diagnostic group of the German Medical-Chemical Task Force entered a chemical agent environment for treatment of victims of a terrorist attack. An anesthetized pig poisoned with sarin emulated a poisoned patient. On arrival, the pig (∼20 kg) displayed typical clinical signs of cholinergic crisis; salivation, miosis and dyspnoea. Using the Test-Mate® system marked inhibition of AChE verified poisoning with a cholinesterase inhibitor within a few minutes. After administration of the oxime HI-6 (260 mg) in combination with atropine (0.6 mg) (bolus dose), a rapid increase in RBC-AChE activity was recorded on site. This was clearly accompanied by prompt clinical improvement, indicating the effectiveness of the oxime treatment. To simulate the situation following rescue and decontamination, two additional pigs were poisoned with sarin and treated at a field intensive care unit. Here, HI-6 or obidoxime were administered in combination with atropine. As observed in the field, the clinical situation improved after oxime treatment, however repetitive atropine doses were necessary to counteract hypersalivation. In one pig, diazepam was also required due to convulsions. These animals were maintained under anaesthetic for approximately two hours, during which time their blood was sampled. RBC-AChE activity as well as plasma BChE activity were determined on site to monitor the course of treatment. In addition, blood samples were sent to our laboratory in Munich and were reanalysed with an automated analysis system (Tecan RMP). Comparison of the results showed almost identical values independent of the analytic system used (Figure 2, upper panel) .
INVESTIGATION OF NEUROMUSCULAR TRANSMISSION
Investigations on muscle strips of various species revealed that oximes were able to restore force to muscles paralysed by OP; however, several therapeutic gaps (e.g. soman) still exist (30) (31) (32) (33) (34) (35) (36) . Aside from an unknown direct oxime reaction, recovery of muscle force was mainly attributed to the reactivation of inhibited muscle AChE. A series of experiments on phrenic nerve-diaphragmpreparations of mice circumfused with paraoxon showed that obidoxime restored muscle force, and this was clearly accompanied by an increase in muscle AChE activity (36) . Comparably, in patients with insecticide OP-poisoning, it was reported that low RBC-AChE activity (<10 %) was associated with marked decrement-phenomena (23) (stimulation of a nerve with frequencies of 30 Hz to 50 Hz and recording of compound action potentials), indicating severe disturbance of neuromuscular transmission and urgent requirement of artificial ventilation (37, 38) . At RBC-AChE activity of about 15 % to 20 % mainly decrement-increment-phenomena occurred (23) . This type of response is typically found in moderate to severe poisoning (37, 38) , presumably also indicating the need for artificial ventilation. At RBC-AChE activity above 30 %, little disturbance of neuromuscular transmission could be detected (23) . AChE is encoded on a single gene in mammalian species (39) , and therefore a similar structure may be assumed to occur throughout the body (2, 40, 41) . Consequently, RBC-AChE should have comparable functional properties to synaptic AChE and therefore may be used as surrogate parameter, reflecting the AChE status at the synaptic site. However, when RBC-AChE ages completely, restoration takes several months (42) while synaptic AChE recovers faster (43, 44) . Therefore, under these conditions, RBC-AChE can no longer be regarded as a suitable parameter to indicate the end of the cholinergic crisis. As BChE may show quite different properties concerning inhibition by OPs as well as reactivation of the inhibited enzyme by oximes (2, 45) , this parameter has to be used 
RECOMMENDATION FOR DIAGNOSIS AND TREATMENT OF PATIENTS POISONED BY ORGNOPHSPHORUS COMPOUNDS
RBC-AChE activity should be determined as early as possible to confirm the diagnosis of poisoning by inhibitors of cholinesterase.
Atropine should be given according to clinical signs and symptoms using a regime which ensures fast atropinisation without overdosing, e.g. doubling the doses every 5 min after a starting dose with 2 mg.
Effective oximes should be administered at appropriate doses as early as possible to OP-poisoned patients.
The effects of oximes may be assessed using the cholinesterase status, thus allowing optimal oxime treatment; oximes should be administered as long as reactivation is possible and inhibitory material is present in the patient. Investigation of the neuromuscular transmission should complete the monitoring system as objective clinical parameter. Especially when RBC-AChE activity ages completely, improvement of neuromuscular transmission may be the decisive parameter to indicate the end of the cholinergic crisis. This item urgently needs further investigation.
To aid the on-site physician in optimizing diagnosis and treatment, field test systems should be further advanced to allow for rapid determination of the extended cholinesterase status.
Sa`etak
ACETILKOLINESTERAZA U ERITROCITIMA I BUTIRILKOLINESTERAZA U PLAZMI -VA@NI POKAZATELJI ZA LIJE^ENJE OSOBA OTROVANIH ORGANOFOSFORNIM SPOJEVIMA Inhibicija acetilkolinesteraze (AChE) smatra se primarnim mehanizmom toksi~noga djelovanja organofosfornih spojeva (OP). Strategije lije~enja idu za zaustavljanjem prekomjerne stimulacije muskarinskih receptora atropinom i reaktiviranjem inhibiranog AChE oksimima. Klju~na je reaktivacija u neuromuskularnoj sinapsi, u kojoj atropin nije djelotvoran, budu}i da neuromuskularna blokada u kona~nici vodi do prestanka disanja. Va`no je {to ranije prepoznati otrovanje organofosfornim spojem. U jednoj me|unarodnoj vje`bi za{tite od nuklearnog, biolo{kog i kemijskog napada svinje pod anestezijom otrovane su sarinom te lije~ene atropinom i oksimom. Uzeti su im uzorci krvi te s pomo}u terenskoga testa na licu mjesta odre|ena aktivnost AChE u eritrocitima. Otrovanje je potvr|eno za nekoliko minuta. Nakon primjene HI-6, aktivnost AChE brzo je porasla. Isti su uzorci krvi ponovno analizirani u na{em laboratoriju u Münchenu. Oba su testa zabilje`ila gotovo istovjetan tijek aktivnosti AChE. U Münchenu je me|utim napravljen potpuniji nalaz kolinesteraza. Lije~enje oksimima mo`e se prekinuti kada AChE potpuno "ostari" (tj. dealkilira), ali ga valja nastaviti dokle god je otrov u tijelu, a reaktivacija mogu}a. Lije~nici na terenu trebali bi raspolagati terenskim testovima radi brzoga i potpunog utvr|ivanja statusa kolinesteraza, a time i kvalitetnije dijagnoze. 
